quantic69/iStock via Getty Images
Shares of WW International (NASDAQ:WW) have reversed Thursday’s after-hours gains as guarded remarks from the company’s CEO pertaining to the company’s debt burden and the lingering shortage of GLP-1 medications took some of the wind out of Q4 results.
In